Criteria for judging the immune markers of COVID-19 disease vaccines.

Lin, Nan; Fu, Haoxuan; Pu, Dan; Quan, Yuxin; Li, Yueyi; Yin, Xiaomeng; Wei, Yuhao; Wang, Hang; Ma, Xuelei; Wei, Xiawei

Lin, Nan; Fu, Haoxuan; Pu, Dan; Quan, Yuxin; Li, Yueyi; Yin, Xiaomeng; Wei, Yuhao; Wang, Hang; Ma, Xuelei; Wei, Xiawei.

Afiliación

Lin N; West China School of Medicine West China Hospital Sichuan University Chengdu China.
Fu H; Department of Statistics University of Illinois at Urbana Champaign Urbana Illinois USA.
Pu D; Department of Radiation Oncology Cancer Center, West China Hospital, Sichuan University Chengdu China.
Quan Y; West China School of Medicine West China Hospital Sichuan University Chengdu China.
Li Y; Department of Biotherapy Cancer Center, West China Hospital, Sichuan University Chengdu China.
Yin X; Department of Biotherapy Cancer Center, West China Hospital, Sichuan University Chengdu China.
Wei Y; West China School of Medicine West China Hospital Sichuan University Chengdu China.
Wang H; West China School of Medicine West China Hospital Sichuan University Chengdu China.
Ma X; Department of Biotherapy Cancer Center, West China Hospital, Sichuan University Chengdu China.
Wei X; Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University Chengdu China.

MedComm (2020) ; 3(1): 1-12, 2022 Jan.

Article en En | MEDLINE | ID: mdl-35005708

Palabras clave

SARSCoV2; assessment; neutralizing antibodies; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: MedComm (2020) Año: 2022 Tipo del documento: Article Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google